-
Information about:
- Products Outside US
-
Information for US:
- Patients
- Physicians
- Labs
Cervical Cancer Screening
BD SurePath™ Process
|
BD SurePath™ liquid-based Pap test is a FDA-approved process intended for use in screening and detection of cytologic categories*. The BD SurePath™ collection process is a simple 3 step process which ensures 100% of the collected sample is sent to the laboratory.
In the lab, the vial goes through the process of BD SurePath™ Cell Enrichment which substantially removes blood, mucus and up to 50% of inflammatory cells. This improves specimen adequacy and may reduce repeat testing. A slide is then prepared using the The BD SurePath™ process – an accurate analysis of cytologic sample to provide you the right result.
|
|||||||



